Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM

Human Immunology

Volumn 45, Issue 1, 1996, Pages 13-23

  Robbins, Ninette F ^a,b   Hammond, Craig ^a   Denzin, Lisa K ^a   Pan, Mary ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Palmetto Richland Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA D ANTIGEN; HLA DM ANTIGEN; LEUPEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ARTICLE; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; INTRACELLULAR TRANSPORT; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE COMPONENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSPORT KINETICS;

EID: 0029979452     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(95)00152-2     Document Type: Article

References (48)

1. d. Science 256:1817, 1992.
2. Rudensky AY, Preston-Hurlburt P, Hong S-C, Barlow A, Janeway Jr CA: Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622, 1991.
3. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL: Predominate naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764, 1992.
4. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27, 1993.
5. Newcomb JR, Cresswell P: Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant-chain associated αβ dimers. J Immunol 150:499, 1993.
6. Roche PA, Marks S, Cresswell P: Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392, 1991.
7. Lamb CA, Cresswell P: Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunol 148:3478, 1992.
8. Roche PA, Cresswell P: Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615, 1990.
9. Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Peterson PA: Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600, 1990.
10. Lamb CA, Yewdell JW, Bennink JR, Cresswell P: Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc Natl Acad Sci USA 88:5998, 1991.
11. Chervonsky AV, Gordon L, Sant A: A segment of the MHC class II β chain plays a critical role in targeting class II molecules to the endocytic pathway. Int Immunol 6: 973, 1994.
12. Blum JS, Cresswell P: Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 85:975, 1988.
13. Neefjes JJ, Ploegh HL: Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J 11:411, 1992.
14. Maric MA, Taylor MD, Blum JS: Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci USA 91:2171, 1994.
15. Guagliardi LE, Koppelman B, Blum JS, Marks MS, Cresswell P, Brodsky FM: Colocalization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343:133, 1990.
16. Castellino F, Germain RN: Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73, 1995.
17. Collins DS, Unanue ER, Harding CV: Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol 147:4054, 1991.
18. Harding CV, Collins DS, Slot JW, Geuze HG, Unanue ER: Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64:393, 1991.
19. Qui Y, Xu X, Wandinger-Ness A, Dalke DP, Pierce SK: Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol 12: 595, 1994.
20. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ: Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669, 1991.
21. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J: Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120, 1994.
22. West MA, Lucocq JM, Watts C: Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369:147, 1994.
23. Rudensky AY, Maric M, Eastman S, Shoemaker L, De-Roos P, Blum JS: Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1:585, 1994.
24. Amigorena S, Drake JR, Webster P, Mellman I: Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369: 113, 1994.
25. Fling SP, Arp B, Pious D: HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554, 1994.
26. Morris P, Shaman J, Attaya M, Goodman S, Bergman C, Monaco JJ, Mellins E: An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551, 1994.
27. Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P: Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1:595, 1994.
28. Sanderson F, Kleijmeer MJ, Kelly A, Verwoerd D, Tulp A, Neefjes JJ, Geuze HJ, Trowsdale J: Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566, 1994.
29. Karlsson L, Peleraux A, Linstedt R, Liljedahl M, Peterson PA: Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266: 1569, 1994.
30. Lampson LA, Levy R: Two populations of Ia-like molecules on a human B cell line. J Immunol 125:293, 1980.
31. Clark EA, Yakoshi T: Human B cell and B cell blast-associated surface molecules defined by monoclonal antibodies. In Bernard L, Baunsell L, Dausset J, Schlossman S (eds): Leucocyte Typing. Heidelberg, Germany, Springer-Verlag, 1984.
32. Hochstenbach F, David V, Watkins S, Brenner MB: Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T-and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. Proc Natl Acad Sci USA 89:4734, 1992.
33. Davis JE, Cresswell P: Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique. J Immunol 144:990, 1990.
34. Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC: CD63 antigen: a novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266:3239, 1991.
35. Avva RR, Cresswell P: In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763, 1994.
36. Machamer CE, Cresswell P: Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J Immunol 129:2564, 1982.
37. Pool RR, Maurey KM, Storrie B: Characterization of pinocytic vesicles from CHO cells: resolution of pinosomes from lysosomes by analytical centrifugation. Cell Biol Int Rep 7:361, 1983.
38. Storrie B, Madden EA: Isolation of subcellular organelles. Methods Enzymol 182:2031, 1990.
39. Androlewicz MJ, Anderson KS, Cresswell P: Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci USA. 90:9130, 1993.
40. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P: HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474, 1992.
41. Sette A, Ceman S, Kubo RT, Sakaguch L, Appella E, Hunt DF, Davis TA, Michel H, Shabanowitz J, Rudersdorf R, Grey HM, DeMars R: Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801, 1992.
42. Mellins E, Cameron P, Amaya M, Goodman S, Pious D, Smith L, Arp B: A mutant human hisocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J Exp Med 179:541, 1994.
43. Germain RN, Hendrix LR: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134, 1991.
44. Riberdy JM, Avva RR, Geuze HJ, Cresswell P: Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J Cell Biol 125:1225, 1994.
45. Calafat J, Nijenhuis M, Janssen H, Tulp A, Dusseljee S, Wubbolts R, Neefjes J: Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures. J Cell Biol 126:967, 1994.
46. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S: The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52:329, 1988.
47. Denzin L, Cresswell P: HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155, 1995.
48. Romagnoli P, Layet C, Yewdell J, Bakke O, Germain RN: Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 177:583, 1993.